Home » Success Stories » Assessing and Enabling PDPL and Healthcare Data Privacy Compliance for DMSCO
DMSCO is a leading retail pharmacy organization undergoing transformation into a broader healthcare service provider, operating within an increasingly regulated data protection environment.
To support its expansion into regulated healthcare markets, the organization required a structured approach to achieving compliance with Saudi Arabia’s Personal Data Protection Law and international healthcare data protection standards.
This engagement delivered a comprehensive privacy and compliance assessment, enabling improved visibility into data practices, identification of regulatory gaps, and the development of a clear roadmap toward full compliance.
Limited visibility into data privacy compliance and gaps against PDPL and healthcare standards
Comprehensive data privacy assessment with gap analysis and structured compliance roadmap
Clear compliance posture, improved risk visibility, and a defined path toward regulatory alignment
Conducted detailed assessments of data processing practices across the organization
Evaluated compliance against Personal Data Protection Law and healthcare data protection standards such as HIPAA
Identified regulatory gaps and operational blind spots impacting compliance
Developed current, transitional, and target state models for data privacy compliance
Delivered an executive-level roadmap outlining prioritized actions for achieving compliance within a defined timeframe
Provided regulatory response advisory and guidance on implementation priorities
Supported stakeholder engagement and awareness to enable consistent adoption across the organization
Recommended tooling and automation to support sustainable privacy management
PDPL and HIPAA-aligned data privacy assessment
Executive-level compliance roadmap and target state modeling
Stakeholder-driven awareness and enterprise-wide visibility
Through this engagement, DMSCO gained a clear and structured pathway to achieving data privacy compliance, enabling stronger governance, reduced risk, and readiness for expansion into regulated healthcare markets.
